BrainStorm Cell Therapeutics names Peter J. Pitts executive chairman
BCLI•BrainStorm Cell Therapeutics appointed Peter J. Pitts executive chairman and chief strategic regulatory and policy officer on July 28, 2026. Jacob Frenkel transitioned to senior adviser.
1. Leadership changes
Pitts, a former FDA associate commissioner and co-founder of the Center for Medicine in the Public Interest, joined the board in May 2026. Frenkel had been board chairman since 2020 and a leadership team member since 2007.




